Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avicanna Inc (OP:AVCNF)

0.1758 +0.0058 (+3.41%)
Streaming Delayed Price Updated: 10:55 AM EDT, May 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,300
Open 0.1758
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1700
Today's Range 0.1758 - 0.1758
52wk Range 0.1150 - 0.3762
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More
Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Cannabis-Focused Biopharma Co. Avicanna Traded Up 26%+ Today
Shares of Avicanna Inc. 
Via Benzinga

Performance

YTD
-19.4%
-19.4%
1 Month
-0.1%
-0.1%
3 Month
-8.7%
-8.7%
6 Month
-12.4%
-12.4%
1 Year
-30.8%
-30.8%

More News

Read More
The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook
Via Benzinga
Topics Cannabis
Exposures Cannabis
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Investor Forum Agenda Announced for March 13th
From Virtual Investor Conferences
Via GlobeNewswire
This Week In Cannabis: Rescheduling Delays, The DEA, Biden's Clemency, Philip Morris' New Bet And More
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Reduces Net Loss And Improves Gross Profit, Focusing On International Markets
Via Benzinga
Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
Via Benzinga
Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion
Via Benzinga
Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates
Via Benzinga
Topics Cannabis
Exposures Cannabis
Latest Cannabis Hires And Board Changes, Here's What You Need To Know
Via Benzinga
Topics Cannabis
Exposures Cannabis
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Via Benzinga
Topics Cannabis
Exposures Cannabis
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
From Virtual Investor Conferences
Via GlobeNewswire
CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue
Via Benzinga
CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.
Via Benzinga
Topics Cannabis
Exposures Cannabis
Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global
Via Benzinga
Topics Cannabis
Exposures Cannabis
CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal
Via Benzinga
CBD-Focused Avicanna Announces Funding Boost For Research And Development
Via Benzinga
Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform
Via Benzinga
Topics Cannabis
Exposures Cannabis

Frequently Asked Questions

Is Avicanna Inc publicly traded?
Yes, Avicanna Inc is publicly traded.
What exchange does Avicanna Inc trade on?
Avicanna Inc trades on the OTC Traded
What is the ticker symbol for Avicanna Inc?
The ticker symbol for Avicanna Inc is AVCNF on the OTC Traded
What is the current price of Avicanna Inc?
The current price of Avicanna Inc is 0.1758
When was Avicanna Inc last traded?
The last trade of Avicanna Inc was at 05/02/25 10:55 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.